Navigation Links
Statement by Bruce Bodaken on Senate Health Committee Action
Date:1/23/2008

SAN FRANCISCO, Jan. 23 /PRNewswire-USNewswire/ -- The following is a statement by Blue Shield of California CEO Bruce Bodaken on Senate Health Committee Action:

As a longtime advocate for universal coverage, I'm disappointed that we did not clear this hurdle today. We need to get there soon. The Senate must not make perfection the enemy of the good. This bill should be evaluated against what is, not what ought to be.

We have waited too long to make health coverage for all a reality. Every day of political wrangling is a day more than 6 million Californians go without access to regular medical care.

The governor, speaker and pro-tem have provided the vision and leadership to bring California to the precipice of a profound change for the better. I hope that in the coming days, senators will think hard about the consequences of inaction.

CONTACT: David Seldin, Director of Corporate Communications of Blue Shield of California, +1-415-229-5366, david.seldin@blueshieldca.com


'/>"/>
SOURCE Blue Shield of California
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1

Related medicine news :

1. Statement of Eli Lilly and Company on Dr. David Egilman Settlement:
2. Takeda statement on ACTOS meta-analysis published in the Journal of the American Medical Association
3. Takeda Statement on ACTOS(R) (Pioglitazone HCl) Meta-Analysis Published in the Journal of the American Medical Association
4. Statement by Mike Leavitt Secretary of Health and Human Services on the United States-China Bilateral Meetings on Food and Drug Safety
5. Statement by Oscar S. Wyatt, Jr.
6. Statement from Employment Policies Institute on Senator Hillary Clintons Health Care Plan
7. Pelosi Statement on Proposed Entitlement Task Force
8. Statement by Robert Greenstein, Executive Director of the Center on Budget and Policy Priorities, on the New Congressional SCHIP Agreement
9. Statement on House/Senate Agreement on SCHIP Legislation
10. Statement from the Alliance for Quality Nursing Home Care
11. Produce for Better Health Foundation Releases Statement on Study Saying Fruit & Vegetable Consumption Not Strongly Associated With Colon Cancer Risk

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/28/2009)...ariation believed to affect circadian rhythm, ,... New research suggests that an internal body clock...evelopment of bipolar disorder in children. , ...netic makeup of 152 children with bipolar disorder...swings, and 140 children without the disorder. The...
(Date:11/27/2009)...RD, Mass., Nov. 27 GSI G...upplier of precision technology products and semic...eeting of the Company,s shareholders has been sche...cation of the meeting will be announced in due cou...d a requisition notice from Stephen Bershad, a hol...
(Date:11/27/2009)... Biotech firm Replikins Ltd. today issued i...enomic data. It shows that the lethality of the v...uring the virus,s current outbreak in the spring o... 2.0 (s.d. 0.1). The H1N1 infectivity count, howev...Boston (PRWEB) November 27, 2009 -- Biotech firm R...
(Date:11/27/2009)...NCISCO, Nov. 27 The Gymb...lair Lambert, CFO/COO, will present at the NASDAQ ...he May Fair Hotel in London, England, on Wednesday...sten to a live broadcast of The Gymboree Corporati... to www.gymboree.com, click on "Our Company" at th...
(Date:11/27/2009)...LLY-SUR-SEINE, France, Nov. 27 Tea...al cycling team dedicated to ethical sporting and ...s, announced today that it will become Team Garmin...cal as a new sponsor of the team. Transitions Opti...e eyewear, offering the most advanced photochromic...
Breaking Medicine News(10 mins):Health News:Bipolar Disorder May Be Tied to Body Clock 2Health News:GSI Group Calls Shareholders Meeting 2Health News:Lethality of H1N1 Virus Drops to "Non-Epidemic Resting Levels" in Current Cycle; Virus' Infectivity Remains Increased 2Health News:Lethality of H1N1 Virus Drops to "Non-Epidemic Resting Levels" in Current Cycle; Virus' Infectivity Remains Increased 3Health News:Lethality of H1N1 Virus Drops to "Non-Epidemic Resting Levels" in Current Cycle; Virus' Infectivity Remains Increased 4Health News:Lethality of H1N1 Virus Drops to "Non-Epidemic Resting Levels" in Current Cycle; Virus' Infectivity Remains Increased 5Health News:Team Garmin-Slipstream Officially Re-named Team Garmin-Transitions With Addition of Transitions Optical as New Sponsor 2Health News:Team Garmin-Slipstream Officially Re-named Team Garmin-Transitions With Addition of Transitions Optical as New Sponsor 3
...s health plans in member satisfaction in four key ... Kaiser Permanente announced today that its member...n,s health plans highest in customer satisfaction ...west. These plans serve almost 7.5 million of Kai...
... include improved patient outcomes and , real-time... Somanetics Corporation (Nasdaq: SMTS ) announc... and Drug Administration (FDA) to expand the label...sed to manage therapies in patients above 2.5 kilo...
...l 16 Vion Pharmaceuticals, Inc. (OTC Bulletin Bo...ication (NDA) for its lead oncology therapeutic On...r review by the U.S. Food and Drug Administration ...gent for remission induction treatment for patient...
...Will Earn Decision Resources, Clinical Gold Standa...g to a New Report from Decision Resources , , WAL...the world,s leading research and advisory firms fo... that most influences their prescribing decisions ...
...and Vitamins Play an Important Role in Preventing ...rriors take note: Bursts of high-energy athletic a...lined by injury from overexertion. Overall wellnes...dy shows 91 percent of orthopedic specialists woul...
...d HIV business with the independence and sustainab...ment, access and shareholder value , - Renews focu... more new HIV treatments , - Equity split of 85% G...e entered into an agreement to create a new world-...
Other Medicine News:Health News:Kaiser Permanente Receives Top Marks in 2009 J.D. Power and Associates Study 2Health News:Kaiser Permanente Receives Top Marks in 2009 J.D. Power and Associates Study 3Health News:Kaiser Permanente Receives Top Marks in 2009 J.D. Power and Associates Study 4Health News:Somanetics Announces New FDA 510(K) Clearance 2Health News:Somanetics Announces New FDA 510(K) Clearance 3Health News:Vion Pharmaceuticals' New Drug Application for Onrigin(TM)Accepted For Review by the FDA 2Health News:Vion Pharmaceuticals' New Drug Application for Onrigin(TM)Accepted For Review by the FDA 3Health News:For Ulcerative Colitis, Surveyed Experts Indicate That Corticosteroids Have Advantages Over Remicade in the Induction of Remission 2Health News:For Ulcerative Colitis, Surveyed Experts Indicate That Corticosteroids Have Advantages Over Remicade in the Induction of Remission 3Health News:Video: Helping Weekend Warriors Stay in the Game 2Health News:Video: Helping Weekend Warriors Stay in the Game 3Health News:GlaxoSmithKline and Pfizer Announce Innovative Agreement to Create a New World-Leading, Specialist HIV Company 2Health News:GlaxoSmithKline and Pfizer Announce Innovative Agreement to Create a New World-Leading, Specialist HIV Company 3Health News:GlaxoSmithKline and Pfizer Announce Innovative Agreement to Create a New World-Leading, Specialist HIV Company 4Health News:GlaxoSmithKline and Pfizer Announce Innovative Agreement to Create a New World-Leading, Specialist HIV Company 5Health News:GlaxoSmithKline and Pfizer Announce Innovative Agreement to Create a New World-Leading, Specialist HIV Company 6Health News:GlaxoSmithKline and Pfizer Announce Innovative Agreement to Create a New World-Leading, Specialist HIV Company 7Health News:GlaxoSmithKline and Pfizer Announce Innovative Agreement to Create a New World-Leading, Specialist HIV Company 8Health News:GlaxoSmithKline and Pfizer Announce Innovative Agreement to Create a New World-Leading, Specialist HIV Company 9
(Date:11/25/2009)..., PRINCETON, N.J., Nov. 25 /PRNewswire-FirstCall/...stage pharmaceutical company committed to discover... treat viral infections, reported financial result... September 30, 2009 Pharmasset held $58.4 million ...ts. ,, Pipeline Update and 2009 Highlights ,...
(Date:11/25/2009)..., CHICAGO and STAFA, Switzerland, Nov. 25 /PRNewsw...manufacturer of innovative hearing solutions, pres...dults Conference, focusing on the special needs of...ther leading experts in aging and audiology from a...ork everyday with older people with hearing loss f...
(Date:11/25/2009)... BRIDGEWATER, N.J., Nov. 25 The FD... (etravirine) tablets, a non-nucleoside reverse tr...ly NNRTI specifically indicated for use in treatme...ic failure with HIV-1 strains resistant to an NNRT...itional approval is based on 48-week data from two...
Breaking Medicine Technology:Pharmasset Reports Fiscal Year End 2009 Financial Results 2Pharmasset Reports Fiscal Year End 2009 Financial Results 3Pharmasset Reports Fiscal Year End 2009 Financial Results 4Pharmasset Reports Fiscal Year End 2009 Financial Results 5Pharmasset Reports Fiscal Year End 2009 Financial Results 6Pharmasset Reports Fiscal Year End 2009 Financial Results 7Pharmasset Reports Fiscal Year End 2009 Financial Results 8Pharmasset Reports Fiscal Year End 2009 Financial Results 9Pharmasset Reports Fiscal Year End 2009 Financial Results 10Phonak Successfully Hosts Hearing Care for Adults 2009 Conference 2Phonak Successfully Hosts Hearing Care for Adults 2009 Conference 3U.S. Food And Drug Administration (FDA) Grants Traditional Approval for INTELENCE(R) (etravirine) 2U.S. Food And Drug Administration (FDA) Grants Traditional Approval for INTELENCE(R) (etravirine) 3U.S. Food And Drug Administration (FDA) Grants Traditional Approval for INTELENCE(R) (etravirine) 4U.S. Food And Drug Administration (FDA) Grants Traditional Approval for INTELENCE(R) (etravirine) 5Soy in the Diet May Protect Lung Function 50201 1The Psychology of Celebrity Worship 50198 1The Psychology of Celebrity Worship 50198 2The Psychology of Celebrity Worship 50198 3CareFusion Names Robert Friel to Board of Directors 50196 1CareFusion Names Robert Friel to Board of Directors 50196 2CareFusion Names Robert Friel to Board of Directors 50196 3
...ta from two Phase 3 trials show clinical success r...ibiotic therapy, WELLESLEY HILLS, Mass., March 13... announced today the presentation of,a poster enti...y for,Treating Infected Diabetic Foot Ulcers: A Ra...rial of Pexiganan Cream." The poster will be,prese...
...S, March 12 Eli Lilly and Company,(NYSE: LLY ), ...mpany,practices as alleged by the Connecticut Atto...issued March 11, 2008., The tone and content of t...rently be taking Zyprexa to treat a life-threateni...ed no acknowledgement of the,seriousness of schizo...
Other Medicine Technology:MacroChem Announces Presentation of Pexiganan Phase 3 Study Results for Topical Treatment of Diabetic Foot Infection 2MacroChem Announces Presentation of Pexiganan Phase 3 Study Results for Topical Treatment of Diabetic Foot Infection 3MacroChem Announces Presentation of Pexiganan Phase 3 Study Results for Topical Treatment of Diabetic Foot Infection 4MacroChem Announces Presentation of Pexiganan Phase 3 Study Results for Topical Treatment of Diabetic Foot Infection 5Statement from Eli Lilly and Company: Response to Connecticut Attorney General News Release 2Statement from Eli Lilly and Company: Response to Connecticut Attorney General News Release 3Statement from Eli Lilly and Company: Response to Connecticut Attorney General News Release 4
...ence laboratory and a worldwide leader in innovati...s an extensive test menu of highly complex and uni...gy. Owned by the University of Utah, ARUP Laborato...'s university teaching hospitals and children's ho...
...ence laboratory and a worldwide leader in innovati...s an extensive test menu of highly complex and uni...gy. Owned by the University of Utah, ARUP Laborato...'s university teaching hospitals and children's ho...
...ence laboratory and a worldwide leader in innovati...s an extensive test menu of highly complex and uni...gy. Owned by the University of Utah, ARUP Laborato...'s university teaching hospitals and children's ho...
...ence laboratory and a worldwide leader in innovati...s an extensive test menu of highly complex and uni...gy. Owned by the University of Utah, ARUP Laborato...'s university teaching hospitals and children's ho...
Medicine Products: